@prefix this: <http://purl.org/np/RASraUVoS8zsKeorvkbC7NiyKltXd4_RupZhLEoMDUyTc> .
@prefix sub: <http://purl.org/np/RASraUVoS8zsKeorvkbC7NiyKltXd4_RupZhLEoMDUyTc#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://identifiers.org/chembl.compound/CHEMBL1201187> a biolink:ChemicalEntity;
    rdfs:label "Maraviroc";
    biolink:category biolink:ChemicalEntity .
  
  sub:_1 rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/chembl.compound/CHEMBL1201187>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1967dc24-f2a5-4095-baa9-a9d1c5410311> .
  
  sub:_2 rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/chembl.compound/CHEMBL1201187>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1967dc24-f2a5-4095-baa9-a9d1c5410311> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-10T14:39:01.856927"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627;
    prov:wasQuotedFrom "Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. The drug is available in the US and Europe for adults and children with HIV-1 infection." .
  
  biolink: pav:version "2.3.0" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
    npx:hasSignature "Ql9M+2VhS8KK6bo/4+OG350Ujq3DSmS0sZK37FEuPnThK3s0EDDA6q4HFvd0N4VguMXKqrs06h+uUe6FVWcVe9gJ4KDumq4pePRVlqVSZyfzqSdGk1UCaYFj+z+2N7b6feD2DTR/fSMgj+NW5VGT9cNGdyRVZRQqcxSGKcYVHlJaLiMQNKAsFc6LV9zT9kq8kjGntpQDTkpOun4IZmHoda6lFp06e9AuNenghdI1VfLxTuTUHAyM76FPQGuyAHF67/B/Xjza9IWrRlHoo4zkNjNPQXF8K18Xu2rDmSivQnMq1GG83CEJQvxXwKAFqTyFAjNpIy1rBNBg2ZiXto8PGg==";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-10-10T14:39:01.856927"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}